BioSpace News Archive

Business

IRRAS Announces Collaboration with Aarhus University Hospital, Scandinavian Leader in Neurosurgery, to Advance Use of IRRAflow

The collaboration with Aarhus University’s neurosurgical team will evaluate IRRAflow during the treatment of Intraventricular Hemorrhage (IVH) and assessment of brain compliance

April 6, 2021
·
4 min read
Policy

Azafaros Enters Clinical Stage With AZ-3102, an Oral Small Molecule Being Developed for Rare Neurogenetic Disorders

Phase 1 clinical study investigates safety and tolerability, pharmacokinetics and pharmacodynamic effects of first-in-class azasugar AZ-3102 in healthy subjects

April 6, 2021
·
4 min read
Deals

Metrion Biosciences Closes £2.7m New Equity Financing

Metrion Biosciences Limited, the specialist ion channel CRO and drug discovery company, announced that it has secured £2.7m in new equity financing, including £2.25m from lead investor Gresham House Ventures.

April 6, 2021
·
2 min read
OBI Pharma Announces Poster Presentations at AACR 2021 Annual Meeting for OBI-3424, OBI-998, Globo H and SSEA-4

Poster Presentations to highlight the latest research on OBI-3424 (AKR1C3 small molecule pro-drug), OBI-998 (SSEA-4 ADC) and the glycosphingolipid cancer antigens, Globo H and SSEA-4.

April 6, 2021
·
4 min read
Business

Opthea Company Secretary Resignation

Opthea Limited advises that Mr Michael Tonroe has resigned as Company Secretary and Chief Financial Officer of the Company, with effect 24 June 2021.

April 6, 2021
·
4 min read
Policy

Amarin Commences Commercial Initiatives for VAZKEPA in European Union Following Recent Regulatory Approval for Cardiovascular Risk Reduction Indication

Amarin Corporation plc provided updates regarding its plans for the commercial launch of VAZKEPA in Europe following the March 30, 2021 announcement of receipt of market authorization from the European Commission.

April 6, 2021
·
16 min read
Deals

RadNet Announces a Proposed Refinancing Transaction for its $611 Million Senior Secured Term Loan and $195 Million Senior Secured Revolving Credit Facility

RadNet, Inc. announced a proposed refinancing transaction for its existing senior secured first lien term loan, which had a balance of $611 million as of December 31, 2020, and its $195 million senior secured revolving credit facility, which was undrawn as of year-end 2020.

April 6, 2021
·
4 min read
Biotech Beach

DuchenneXchange Launches V2.0 As Rare Disease Community Seeks “Safe” Place To Discuss Treatment, Research, COVID-19 Immunization And Other Critical Topics

The volatility of the past year has created additional strain on families grappling with Duchenne muscular dystrophy, a severe X-linked form of muscular dystrophy that affects approximately 1 in 3,500 to 5,000 males born each year.

April 6, 2021
·
4 min read
Drug Development

Positive Phase 1/2 Results for Valneva’s Inactivated COVID-19 Vaccine Candidate Using Dynavax’s CpG 1018™ Adjuvant

VLA2001, an inactivated COVID-19 vaccine candidate with CpG 1018 adjuvant, was highly immunogenic and generally safe and well tolerated

April 6, 2021
·
5 min read
Policy

Biodesix Announces Issuance of Two U.S. Patents, Expands Coverage of Diagnostic Methods to Improve Care for Cancer Patients

Diagnostic Test and Novel Methodologies Designed to Guide Patient Assessment and Treatment Strategies

April 6, 2021
·
5 min read